For drugmaker Pfizer, a fortune amassed in the COVID pandemic is now paving the path to pharma nirvana: a weight loss pill worth billions.
Nov 9, 2022
0
19
Scientists at St. Jude Children's Research Hospital have shown how a protein responsible for adapting to low oxygen conditions (hypoxia), causes increased expression of fetal hemoglobin (HbF) in adults. The finding has implications ...
Oct 12, 2022
0
50
A Yale Medicine orthopedic surgeon has developed an innovative procedure that uses a patient's own stem cells to treat a condition that can cause painful hip fractures.
Oct 10, 2022
0
20
One of the many risks associated with heart attacks and cardiac surgery is acute kidney injury, a serious condition that in some cases can lead to kidney failure.
Oct 7, 2022
0
39
New educational materials to help the sickle cell disease community learn about gene therapies for the disease are now available from researchers at the National Human Genome Research Institute (NHGRI), part of the National ...
Sep 28, 2022
0
9
Too few U.S. kids with sickle cell anemia get a needed screening for stroke, according to a study released Tuesday.
Sep 20, 2022
0
0
Bluebird Bio Inc.'s gene therapy for a brain-wasting disease received accelerated approval from U.S. regulators, making it the first treatment of its kind for children living with cerebral adrenoleukodystrophy.
Sep 19, 2022
0
4
A network that receives and supplies blood for transfusions nationwide is calling for more diverse blood donors.
Sep 6, 2022
0
7
People in the United Kingdom with folic acid prescriptions were 1.5 times more likely to get COVID-19. They were also 2.6 times more likely to die from COVID-19 compared to the control group. Those are the findings of a new ...
Aug 31, 2022
0
92
Researchers at Children's Hospital of Philadelphia (CHOP) have discovered a new part of the regulatory cascade responsible for silencing fetal hemoglobin in adult cells. The findings, published today in Nature Genetics, refine ...
Aug 8, 2022
0
53
